Health Condition 1: - Health Condition 2: J309- Allergic rhinitis, unspecified
Conditions
Interventions
Intervention1: Montelukast with Fexofanadiene: 10mg+120mg once a day then followup after 15 days,1month,2month,3month.
Control Intervention1: Montelukast with Levocetirizine: 10mg+5mg once a day then
Sponsors
Dr Preeti Sahani
Eligibility
Inclusion criteria
Inclusion criteria: Male & females aged 18 years and 65 years All diagnosed patients with Allergic Rhinitis attending the outpatient department BRD Medical college Gorakhpur Patients giving written informed consent will be taken
Exclusion criteria
Exclusion criteria: Patients with a history of hypersensitivity to study drugs Significant comorbid conditions such as Hypertension and Diabetes Mellitus Those on concurrent medications that might interfere with the study Pregnant and Lactating women Not giving consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in the Total Nasal Symptom Score over 15 days 1st month 2nd month and 3rd monthTimepoint: Reduction in the Total Nasal Symptom Score over 15 days 1st month 2nd month and 3rd month | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety assessment through monitoring adverse events Patient reported quality of life using the Rhinoconjunctivitis Quality of Life Questionnaire Patient satisfaction assessed through a Visual Analog ScaleTimepoint: 15 days,1month,2month,3months. | — |
Countries
India
Contacts
Public ContactDr Preeti Sahani
B.R.D.Medical College
Outcome results
None listed